Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News C2N’s PrecivityAD2 blood test improves Alzheimer’s diagnosis and clinical decision-making, study finds A new study has demonstrated that healthcare providers who used the PrecivityAD2 blood biomarker test, developed by C2N… byPallavi MadhirajuJanuary 31, 2025